Aldara Imiquimod: A Revolutionary Topical Treatment for Basal Cell Carcinoma (BCC)

Skin Cancer Treatments

Skin cancer remains one of the most prevalent types of cancer worldwide, affecting millions of people every year. Basal cell carcinoma (BCC) is the most common form of skin cancer, accounting for about 80% of non-melanoma cases. While typically not life-threatening, BCC can be disfiguring and require extensive surgical interventions. However, thanks to advancements in dermatological research, a topical cream named Aldara Imiquimod has emerged as a game-changer in treating BCC.

Understanding Basal Cell Carcinoma (BCC):

Before delving into Aldara Imiquimod’s significance, let’s briefly explore BCC. Basal cell carcinoma originates from basal cells responsible for regenerating skin tissue. It typically develops due to prolonged exposure to ultraviolet (UV) radiation, such as excessive sunlight or tanning bed usage. BCC usually appears as a sore or bump on the skin, with a shiny, pearly, or translucent appearance. Though it can occur anywhere on the body, BCC primarily affects areas exposed to the sun, such as the face, ears, neck, and scalp.

Traditional BCC Treatment Methods:

Until recently, surgical interventions such as excision, electrodesiccation and curettage, Mohs surgery, or cryotherapy were BCC’s primary treatment options. While these methods are effective, they often involve removing a significant amount of surrounding healthy tissue, potentially causing scarring and functional limitations, especially on the face. Moreover, due to long waiting times for specialist appointments and surgery, patients sometimes had to endure prolonged discomfort and a delay in treatment.

Enter Aldara Imiquimod:

A novel non-surgical approach, Aldara Imiquimod, has revolutionized the treatment of BCC. Aldara is a cream that contains the active ingredient Imiquimod, a compound that stimulates the body’s immune response against cancer cells. It works by activating specific immune cells called Toll-like receptors, releasing chemicals that trigger an antitumor immune response.

How Aldara Imiquimod Works:

When applied to the affected area, Aldara Imiquimod helps to stimulate the immune system, encouraging the body to attack and destroy cancerous cells. The cream is typically applied five times a week for six weeks, allowing the immune response to target and eliminate BCC effectively. Clinical studies have shown impressive cure rates and improved cosmetic outcomes using Aldara Imiquimod.

Advantages and Limitations:

Aldara Imiquimod boasts several advantages over traditional BCC treatment methods. Firstly, it provides a non-invasive option, reducing the need for surgery and potential scarring. Secondly, it allows for convenient home treatment, eliminating the need for repeated specialist visits and lowering the burden on healthcare systems. Moreover, Aldara Imiquimod is suitable for various BCC subtypes, making it a versatile treatment option.

However, it is essential to note that not all BCC cases are appropriate for Aldara Imiquimod treatment. Some aggressive and invasive forms of BCC may require surgical intervention. Additionally, patients may experience mild to moderate side effects such as redness, itching, and flaking at the application site. These side effects are generally well-tolerated and subside once treatment is completed.

Conclusion:

Aldara Imiquimod has emerged as a groundbreaking topical treatment for basal cell carcinoma. By harnessing the body’s immune response, this cream offers a viable, non-surgical alternative with impressive cure rates and improved cosmetic outcomes. While it may not be suitable for all BCC cases, Aldara Imiquimod represents a significant step forward in the fight against skin cancer. As always, consulting with a dermatologist or healthcare professional is essential for an accurate diagnosis and personalized treatment plan.

Melanoma and Skin Cancer News

At Drummoyne Dermatology we will provide you with the latest news and research on Melanoma and Skin Cancer. Read recent authoritative articles on Skin Cancer and Melanoma.

Radiotherapy

Radiotherapy for skin cancers is usually for patients over 60yrs, with large or difficult to treat tumours. The advantage of radiotherapy for  these tumours  is that a skin graft or flap is avoided. The treatment is painless and the patient does not feel sick or...

Photodynamic Therapy (PDT)

Photodynamic therapy (PDT) is treatment  for superficial types of skin cancer. PDT is effective in treating solar keratoses, squamous cell carcinoma in situ (Bowen’s disease) and superficial basal cell carcinomas. It has a cure rate of approximately 80%. PDT or...

Efudix Treatment

Efudix is a topical cream that is commonly used to treat precancerous skin conditions, such as actinic keratosis and Bowen’s disease. The cream contains a powerful medication called fluorouracil, which works by killing rapidly dividing cells. It is typically applied to the affected area once or twice daily for several weeks.

Treatment of Warts with Duofilm

  BUY Duofilm extrastrength gel Brown elastoplast tape or waterproof Leukoplast tape. Duofilm extrastrength gel needs a prescription made up by a compounding pharmacy. DIRECTIONS Apply Duofilm extrastrenth gel to wart after shower. “Set” with hairdryer (low heat) –...

General Skin Checks

Early detection of skin cancer is crucial. Most skin cancers can be successfully treated if detected early. On an average day any one of our dermatologists may find ten skin cancers which may have otherwise gone undiagnosed. If you notice any new spots or changes in...

Treatment of Scars

Scars are an inevitable part of our lives, as they can occur from a variety of causes. Whether it’s from an injury, surgical procedure, or even from acne or stretch marks, scars can leave a lasting mark on both our physical appearance and emotional well-being. Fortunately, dermatologists specialise in the treatment of scars and offer a range of effective solutions to minimise their appearance and restore confidence.

Book your Appointment from 8 am to 4:30 pm
Monday-Friday

Phones unattended 12:00 pm - 1:00 pm

Suite 1, 109 Victoria Road, Drummoyne NSW 2047